JournalTOCs

Expert Opinion on Emerging Drugs
Journal Prestige (SJR): 1.109

Citation Impact (citeScore): 3
Number of Followers: 13

Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1472-8214 - ISSN (Online) 1744-7623
Published by Taylor and Francis

[2648 journals]

Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Amanda W Pong, Jonathan Ross, Ivana Tyrlikova, Alexander J Giermek, Maya P Kohli, Yousef A Khan, Roger D Salgado, Pavel Klein
  Pages: 75 - 90
  Abstract: Volume 27, Issue 1, March 2022, Page 75-90
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-04-01T10:52:25Z
  DOI: 10.1080/14728214.2022.2059464
  Issue No: Vol. 27, No. 1 (2022)
Assessing the developing pharmacotherapeutic landscape in hepatitis B
treatment: a spotlight on drugs in phase II clinical trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Rex Wan-Hin Hui, Lung Yi Mak, Wai-Kay Seto, Man-Fung Yuen
  Pages: 1 - 14
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-05-16T05:42:00Z
  DOI: 10.1080/14728214.2022.2074977
Epidermal growth factor receptor-targeted therapy for the treatment of
non-small cell lung cancer: a review of phase II and III trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Hong-Lian Lu, Guang-Ling Jie, Yi-Long Wu
  Pages: 1 - 16
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-04-15T06:31:04Z
  DOI: 10.1080/14728214.2022.2063836
Emerging drugs for the acute treatment of relapses in adult neuromyelitis
optica spectrum disorder patients
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Edgar Carnero Contentti, Pablo A. López, Juan I. Rojas
  Pages: 1 - 8
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-03-30T12:24:54Z
  DOI: 10.1080/14728214.2022.2059463
Emerging therapies in the management of Irritable Bowel Syndrome (IBS)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Jill E. Elwing, Hadi Atassi, Benjamin D. Rogers, Gregory S. Sayuk
  Pages: 1 - 19
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-03-16T01:57:32Z
  DOI: 10.1080/14728214.2022.2052043
Emerging drugs for the treatment of cutaneous T-cell lymphoma
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Melissa Cheng, Jasmine Zain, Steven T. Rosen, Christiane Querfeld
  Pages: 1 - 10
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-03-08T08:05:57Z
  DOI: 10.1080/14728214.2022.2049233
Emerging drugs for the treatment of paroxysmal nocturnal hemoglobinuria
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Camilla Frieri, Régis Peffault de Latour, Flore Sicre De Fontbrune
  Pages: 1 - 11
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-02-01T07:18:41Z
  DOI: 10.1080/14728214.2022.2031973
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
  Pages: 1 - 18
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-01-25T03:46:55Z
  DOI: 10.1080/14728214.2021.2009800
Recent advances in immune-based approaches for the treatment of
esophagogastric cancer
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: C. S. Weadick, A. G. Duffy, R. J. Kelly
  Pages: 1 - 13
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2022-01-03T09:11:17Z
  DOI: 10.1080/14728214.2021.2020757